ADMA Biologics, Inc.
ADMA
$16.60
$0.020.11%
NASDAQ
| 12/31/2025 | 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 42.75% | -32.01% | 26.05% | -30.56% | 18.96% |
| Total Receivables | 15.08% | 25.47% | 10.38% | 98.83% | -0.28% |
| Inventory | 4.98% | 2.72% | 11.19% | 1.15% | -0.91% |
| Prepaid Expenses | 7.62% | -14.32% | -5.83% | 6.97% | -15.88% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 15.86% | 0.77% | 13.57% | 6.16% | 4.15% |
|
|
|||||
| Total Current Assets | 15.86% | 0.77% | 13.57% | 6.16% | 4.15% |
| Net Property, Plant & Equipment | -8.98% | 18.53% | 1.11% | 3.77% | 1.20% |
| Long-term Investments | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Goodwill | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Total Other Intangibles | 28.72% | -6.83% | 16.59% | -1.74% | -5.15% |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -1.65% | -5.74% | -0.84% | -0.99% | 1,445.57% |
| Total Assets | 9.77% | 1.85% | 9.36% | 4.48% | 25.10% |
|
|
|||||
| Total Accounts Payable | -6.25% | -19.31% | 44.46% | 1.92% | 26.21% |
| Total Accrued Expenses | 17.91% | -0.99% | 3.48% | -19.96% | 18.20% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 7.33% | 223.16% | -5.13% | -2.46% | 2.10% |
| Total Finance Division Other Current Liabilities | 188.43% | -73.69% | 131.33% | 60.49% | 58.39% |
| Total Other Current Liabilities | 188.43% | -73.69% | 131.33% | 60.49% | 58.39% |
| Total Current Liabilities | 23.10% | -24.62% | 40.08% | -3.68% | 23.73% |
|
|
|||||
| Total Current Liabilities | 23.10% | -24.62% | 40.08% | -3.68% | 23.73% |
| Long-Term Debt | -1.08% | -4.51% | 1.20% | 0.26% | -28.61% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -29.28% | 1.03% | 12.09% | -3.07% | -3.43% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -8.17% | -36.67% | -14.54% | -12.20% | -11.68% |
| Total Liabilities | 6.85% | -14.09% | 16.70% | -1.80% | -12.01% |
|
|
|||||
| Common Stock & APIC | 0.85% | 0.68% | 0.89% | -0.38% | 0.80% |
| Retained Earnings | 23.40% | 14.72% | 12.15% | 8.72% | 26.61% |
| Treasury Stock & Other | -38.39% | -53.08% | -- | -- | -- |
| Total Common Equity | 10.70% | 8.25% | 6.67% | 6.99% | 50.51% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 10.70% | 8.25% | 6.67% | 6.99% | 50.51% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 10.70% | 8.25% | 6.67% | 6.99% | 50.51% |
|
|
|||||